Introduction

Functional dysphagia is a functional esophageal disorder classified under the Rome IV framework as category A5. It is characterized by a sensation of solid and/or liquid foods sticking, lodging, or passing abnormally through the esophagus, in the absence of any structural, mucosal, inflammatory, or major motor cause that explains the symptom. Unlike many other causes of dysphagia that carry alarm-level significance and demand urgent investigation, functional dysphagia is ultimately a diagnosis of exclusion made only after a thorough workup has ruled out identifiable pathology.

Dysphagia, broadly defined, is the subjective difficulty or abnormality in swallowing. It affects an estimated 3% to 8% of the general adult population and is one of the most common indications for referral to gastroenterology. Dysphagia is clinically divided into oropharyngeal dysphagia (difficulty initiating a swallow, with food failing to transfer from the oropharynx into the esophagus) and esophageal dysphagia (the sensation that food is obstructed during passage through the esophageal body or at the gastroesophageal junction). Functional dysphagia falls within the esophageal dysphagia category: the patient perceives abnormal bolus transit through the esophagus, yet no organic, structural, or recognized motility-based explanation can be identified.

The Rome IV criteria, published in 2016, provide a standardized diagnostic framework for functional dysphagia within the broader classification of disorders of gut-brain interaction (DGBI). By setting explicit symptom, exclusionary, and temporal requirements, Rome IV enables clinicians to make a positive, criteria-based diagnosis rather than labeling functional dysphagia simply as "unexplained" after negative testing.

Historical Context and Evolution of Esophageal Disorder Classification

The Rome classification of functional esophageal disorders has evolved considerably across its four iterations. Rome I and Rome II provided early frameworks for functional esophageal conditions but offered limited guidance on dysphagia specifically, often grouping it loosely under esophageal motility complaints. Rome III (2006) formally introduced functional dysphagia as a defined entity within the functional esophageal disorders category, requiring the sensation of abnormal bolus passage through the esophagus plus the exclusion of structural disease, GERD, and a named motility disorder.

Rome IV (2016) refined the functional dysphagia criteria in several important ways. First, it expanded the exclusionary framework to explicitly include eosinophilic esophagitis (EoE), which had emerged in the intervening decade as a major and increasingly recognized cause of esophageal dysphagia, particularly in younger adults. Under Rome III, EoE was less prominently addressed; under Rome IV, its exclusion is a specific, named requirement. Second, Rome IV updated the list of major esophageal motor disorders to align with the Chicago Classification of esophageal motility disorders (version 3.0 at the time of publication), providing clear guidance on which manometric diagnoses must be excluded. Third, Rome IV introduced an explicit minimum symptom frequency of at least once per week, adding a quantitative threshold that was absent in earlier iterations.

The Rome IV esophageal disorders category (category A) includes five functional conditions: functional chest pain (A1), functional heartburn (A2), reflux hypersensitivity (A3), globus (A4), and functional dysphagia (A5). Each is a diagnosis of exclusion requiring appropriate investigations, and each reflects an abnormality in the way esophageal sensory signals are processed rather than a detectable structural or motor abnormality. Functional dysphagia occupies a unique position within this category because dysphagia, more than other esophageal symptoms, carries inherent alarm significance and mandates a thorough workup before a functional label can be applied.

The Rome IV Diagnostic Criteria for Functional Dysphagia (A5)

The formal Rome IV diagnostic criteria for functional dysphagia require that all of the following be present:

1. Sense of abnormal bolus transit: A sense of solid and/or liquid foods sticking, lodging, or passing abnormally through the esophagus.
2. Absence of structural or mucosal cause: Absence of evidence that an esophageal mucosal or structural abnormality is the cause of the symptom.
3. Absence of GERD or eosinophilic esophagitis: Absence of evidence that gastroesophageal reflux or eosinophilic esophagitis (EoE) is the cause of the symptom.
4. Absence of major esophageal motor disorders: Absence of major esophageal motor disorders, specifically achalasia/EGJ outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, and absent peristalsis.

Temporal and frequency requirements:

• Criteria must be fulfilled for the last 3 months.
• Symptom onset must have occurred at least 6 months before diagnosis.
• Symptoms must occur at a frequency of at least once per week.

All four diagnostic criteria and all three temporal/frequency requirements must be simultaneously satisfied for a positive diagnosis. The failure of any single element means the Rome IV criteria for functional dysphagia are not met, and alternative diagnoses should be pursued or the patient should be reassessed at a later time.

Criterion 1: Sense of Abnormal Bolus Transit

The first criterion addresses the core symptom: the patient must report a sense of solid and/or liquid foods sticking, lodging, or passing abnormally through the esophagus. This is the phenomenological essence of esophageal dysphagia. Patients may describe food "getting stuck" partway down, a sensation of delayed passage, or an awareness that swallowed material is not moving through the esophagus in a normal fashion.

Several points of clarification are important:

• Solid versus liquid dysphagia: Functional dysphagia may involve solids, liquids, or both. In organic dysphagia, the pattern of solids-only versus solids-and-liquids can help distinguish mechanical obstruction (solids predominate early, with liquids added later as the obstruction worsens) from motility-based causes (solids and liquids may be affected from the outset). In functional dysphagia, neither pattern is diagnostically specific, but careful characterization helps guide the workup.
• Localization: The patient's perception of where the food gets stuck is often imprecise. Studies have demonstrated that patients may localize the sensation of obstruction to the mid or upper chest even when the actual site of delay is at the distal esophagus or gastroesophageal junction. Nevertheless, the symptom must be esophageal in character rather than oropharyngeal.
• Oropharyngeal dysphagia is excluded: Rome IV functional dysphagia does not encompass oropharyngeal (transfer) dysphagia, which involves difficulty initiating a swallow, nasal regurgitation, aspiration, or coughing with swallowing. Oropharyngeal dysphagia is typically caused by neuromuscular disorders (stroke, Parkinson disease, myasthenia gravis, amyotrophic lateral sclerosis), head and neck structural abnormalities (Zenker diverticulum, cricopharyngeal bar, head/neck tumors), or radiation-related fibrosis. These conditions fall outside the Rome IV esophageal disorders framework.
• Bolus impaction is not required: Functional dysphagia does not require complete food bolus impaction (where the patient cannot swallow at all and requires endoscopic disimpaction). Rather, it is a sensation of abnormal passage. Many patients with functional dysphagia can eventually swallow the food but perceive the transit as abnormal.

Criterion 2: Absence of Structural or Mucosal Cause

The second criterion requires that appropriate evaluation has not identified an esophageal mucosal or structural abnormality that explains the dysphagia. This is a critical exclusionary requirement because structural causes of dysphagia are among the most common and, in many cases, the most treatable.

Structural and mucosal causes of esophageal dysphagia that must be excluded include:

• Esophageal stricture: Peptic strictures (from chronic GERD), caustic strictures (from ingestion of corrosive substances), radiation-induced strictures, and anastomotic strictures (post-surgical). These are typically identified on endoscopy or barium esophagography.
• Esophageal rings and webs: Schatzki rings (mucosal rings at the squamocolumnar junction) are one of the most common causes of intermittent solid-food dysphagia. They may be subtle and require a solid bolus challenge (e.g., barium tablet or marshmallow) during fluoroscopic evaluation for detection. Esophageal webs (thin mucosal membranes, typically in the proximal or mid-esophagus) are less common but similarly can cause intermittent dysphagia.
• Esophageal malignancy: Squamous cell carcinoma and adenocarcinoma of the esophagus classically present with progressive dysphagia (initially to solids, then to liquids) accompanied by weight loss. Endoscopy with biopsy is the primary diagnostic modality.
• Extrinsic compression: Mediastinal lymphadenopathy, vascular structures (e.g., dysphagia lusoria from an aberrant right subclavian artery), thoracic aortic aneurysm, or left atrial enlargement can compress the esophagus externally. These causes may be identified on barium swallow, CT scan, or endoscopic ultrasound.
• Esophageal diverticula: Mid-esophageal or epiphrenic diverticula may contribute to dysphagia, particularly when large or associated with concurrent motility disorders.
• Post-surgical anatomy: Patients who have undergone fundoplication (Nissen, Toupet), bariatric surgery (sleeve gastrectomy, gastric bypass), or esophageal surgery may develop dysphagia due to anatomic alteration, wrap migration, or stricture formation.

The primary investigation for excluding structural and mucosal causes is upper endoscopy (esophagogastroduodenoscopy, or EGD). Barium esophagography (including a solid bolus challenge when appropriate) serves as a complementary study that can identify subtle rings, webs, extrinsic compression, and diverticula that may be missed on endoscopy. Cross-sectional imaging (CT or MRI) is reserved for suspected extrinsic compression or malignancy.

Criterion 3: Absence of GERD or Eosinophilic Esophagitis as the Cause

The third criterion requires exclusion of both gastroesophageal reflux disease (GERD) and eosinophilic esophagitis (EoE) as causes of the dysphagia.

GERD-Related Dysphagia

GERD can cause dysphagia through several mechanisms: peptic stricture formation, erosive esophagitis with mucosal edema and inflammation, esophageal dysmotility induced by chronic acid exposure, and esophageal hypersensitivity. Some patients with GERD report dysphagia even without visible mucosal injury, likely due to reflux-induced mucosal sensitization and altered esophageal perception.

Evaluation for GERD-related dysphagia typically involves:

• PPI trial: An empiric 8-week course of twice-daily PPI therapy. Resolution of dysphagia with PPI therapy supports GERD as the cause.
• Ambulatory reflux monitoring: Ambulatory 24-hour pH monitoring (catheter-based or wireless Bravo capsule) or combined pH-impedance monitoring provides objective evidence of pathological acid exposure and reflux-symptom correlation. This testing is typically performed off PPI therapy (for baseline acid exposure assessment) or on PPI therapy (for refractory symptoms).
• Endoscopic findings: Erosive esophagitis (Los Angeles classification grades A through D), Barrett esophagus, or peptic stricture on endoscopy supports a GERD-based etiology.

Eosinophilic Esophagitis (EoE)

EoE has become one of the most important causes of esophageal dysphagia to exclude before diagnosing functional dysphagia. EoE is a chronic, immune-mediated condition characterized by eosinophilic infiltration of the esophageal mucosa (15 or more eosinophils per high-power field on esophageal biopsy). It is increasingly prevalent, particularly in young to middle-aged males with a history of atopic disease (asthma, eczema, allergic rhinitis, food allergies).

EoE can present with intermittent solid-food dysphagia and food bolus impaction, a pattern that can closely mimic functional dysphagia. Endoscopic findings may be subtle (linear furrows, concentric rings or "trachealization," white plaques or exudates, mucosal edema, stricture) or entirely absent in some cases, making biopsies essential for diagnosis.

Rome IV explicitly requires that EoE be excluded as a cause of dysphagia before functional dysphagia can be diagnosed. This means that esophageal biopsies (at least two to four biopsies from both the proximal and distal esophagus) must be obtained during endoscopy to assess for eosinophilic infiltration. If elevated eosinophil counts are found, the diagnosis shifts to EoE (or, if counts are borderline or responsive to PPI, to PPI-responsive esophageal eosinophilia, now considered part of the EoE spectrum under current guidelines).

Criterion 4: Absence of Major Esophageal Motor Disorders

The fourth criterion requires the exclusion of major esophageal motor disorders as defined by the Chicago Classification of esophageal motility disorders. This criterion is assessed through high-resolution manometry (HRM), the current gold-standard test for evaluating esophageal motor function.

The major esophageal motor disorders that must be excluded are:

Achalasia and EGJ Outflow Obstruction

Achalasia is characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent normal peristalsis in the esophageal body. The Chicago Classification (version 4.0, 2021) recognizes three subtypes: Type I (classic achalasia with absent peristalsis and no esophageal pressurization), Type II (panesophageal pressurization with absent peristalsis), and Type III (spastic achalasia with premature or spastic contractions). EGJ outflow obstruction is a related condition with elevated integrated relaxation pressure (IRP) at the esophagogastric junction but with some preserved peristalsis; it may represent early or variant achalasia, or may be caused by mechanical obstruction (hiatal hernia, opioid use, tight fundoplication).

Achalasia is the most important motor disorder to exclude in the workup of dysphagia because it is a progressive condition with well-established treatments (pneumatic dilation, peroral endoscopic myotomy [POEM], laparoscopic Heller myotomy). Missing achalasia and labeling the patient as having "functional dysphagia" would constitute a significant diagnostic error.

Diffuse Esophageal Spasm (DES)

DES is defined by premature contractions (distal latency less than 4.5 seconds) in 20% or more of test swallows, with normal or at least some preserved peristalsis. It can cause dysphagia (and often chest pain) through uncoordinated esophageal contractions that impair normal bolus transport.

Jackhammer Esophagus (Hypercontractile Esophagus)

Jackhammer esophagus is characterized by at least 20% of swallows with a distal contractile integral (DCI) exceeding 8,000 mmHg-s-cm. These hypercontractile contractions can impair bolus clearance and cause dysphagia, chest pain, or both. The condition may be idiopathic or associated with opioid use, EGJ outflow obstruction, or esophageal wall thickening.

Absent Peristalsis

Absent peristalsis is defined by 100% failed peristalsis (DCI less than 100 mmHg-s-cm) on HRM, with normal LES relaxation (distinguishing it from achalasia). It may be seen in systemic sclerosis (scleroderma), severe GERD, or as an idiopathic finding. Absent peristalsis can cause significant dysphagia due to the inability of the esophageal body to propel the bolus toward the stomach.

Minor Motility Disorders and Functional Dysphagia

Importantly, Rome IV requires the exclusion of major motor disorders but does not require the exclusion of minor (or "borderline") motility abnormalities. The Chicago Classification recognizes minor motility disorders such as ineffective esophageal motility (IEM, defined by more than 70% ineffective swallows) and fragmented peristalsis (more than 50% of swallows with large peristaltic breaks). These minor disorders are common, often of uncertain clinical significance, and may coexist with functional dysphagia. Their presence does not preclude a diagnosis of functional dysphagia under Rome IV, provided the major disorders listed above have been excluded.

This distinction is clinically significant because many patients with dysphagia and minor manometric abnormalities do not have a satisfying organic explanation for their symptoms. These patients may be best classified as having functional dysphagia with concurrent minor motility findings, and their management should be approached accordingly.

Temporal and Frequency Criteria

The Rome IV temporal and frequency requirements for functional dysphagia are more detailed than those for some other DGBI, including three separate thresholds:

• 3-month duration: The diagnostic criteria must have been fulfilled for at least the last 3 consecutive months. This ensures the condition is chronic rather than acute or self-limited. Transient dysphagia from medication-induced esophagitis, acute viral esophagitis, or temporary post-procedural edema would not meet this threshold.
• 6-month onset: Symptom onset must have occurred at least 6 months before the time of diagnosis. This confirms that the clinical picture is established and not part of a new or rapidly evolving process that might represent an emerging organic condition.
• Weekly frequency: Symptoms must occur at least once per week on average. This threshold distinguishes functional dysphagia from rare, isolated episodes of abnormal bolus sensation (which may occur in the general population without clinical significance) and ensures a clinically meaningful symptom burden.

All three temporal/frequency criteria must be met simultaneously. A patient with weekly dysphagia that began only four months ago would not satisfy the 6-month onset criterion. A patient with longstanding but infrequent episodes (once or twice per month) would not satisfy the weekly frequency criterion.

Distinguishing Oropharyngeal from Esophageal Dysphagia

Before applying the Rome IV functional dysphagia criteria, the clinician must first determine whether the patient's dysphagia is oropharyngeal or esophageal in origin, as the two have fundamentally different etiologies, workup pathways, and management approaches.

Oropharyngeal (transfer) dysphagia involves difficulty initiating a swallow. Patients may describe food "sticking" in the throat, coughing or choking during swallowing, nasal regurgitation, a sensation that the swallowing mechanism is not working, or a need for multiple swallowing attempts to clear a bolus. Causes include neurological disorders (stroke, Parkinson disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, brain tumors), structural lesions of the oropharynx (Zenker diverticulum, cricopharyngeal bar, oropharyngeal tumors, radiation fibrosis), and muscular disorders (polymyositis, dermatomyositis, inclusion body myositis). The workup involves videofluoroscopic swallowing study (modified barium swallow), fiberoptic endoscopic evaluation of swallowing (FEES), and often neurological assessment.

Esophageal dysphagia involves a sensation of food being obstructed or passing abnormally within the esophageal body or at the gastroesophageal junction. Patients typically localize the sensation to the chest or lower neck. Rome IV functional dysphagia falls within this category. The key clinical question to ask is: "Does the food get stuck in your throat when you try to swallow, or does it go down but then get stuck in your chest?" The former suggests oropharyngeal dysphagia; the latter suggests esophageal dysphagia.

This distinction is essential because Rome IV functional dysphagia criteria were developed for esophageal dysphagia specifically and are not applicable to oropharyngeal causes.

Epidemiology

The epidemiology of functional dysphagia is less well characterized than that of other DGBI, in part because the diagnosis requires extensive exclusionary testing that is not routinely performed in population-based surveys. Most epidemiological data on dysphagia capture the broader category of "uninvestigated dysphagia" rather than Rome-criteria-defined functional dysphagia specifically.

Dysphagia of all causes affects an estimated 3% to 8% of the general adult population. Among patients referred for esophageal evaluation of dysphagia, the proportion ultimately diagnosed with functional dysphagia after thorough workup varies across studies but is estimated at 10% to 30%. This means that functional dysphagia, while less common than structural or reflux-related causes, represents a substantial minority of patients seen in specialized esophageal clinics.

Functional dysphagia appears to affect women somewhat more frequently than men, consistent with the sex distribution of other functional esophageal disorders and DGBI more broadly. The condition occurs across all age groups but is most commonly diagnosed in adults aged 30 to 60. Older patients presenting with new-onset dysphagia require particularly careful exclusion of organic causes (malignancy, stricture, neurological disease) before a functional diagnosis is considered.

Risk factors for functional dysphagia include psychological comorbidity (anxiety, somatization, health-related hypervigilance), a history of other DGBI (functional heartburn, globus, IBS, functional dyspepsia), and possibly a history of prior esophageal or oropharyngeal illness or procedure that may have sensitized the esophageal afferent pathways even after the original condition has resolved.

Pathophysiology

The pathophysiology of functional dysphagia is incompletely understood, but several mechanisms have been proposed. In essence, functional dysphagia represents an abnormality in the perception and/or central processing of esophageal sensory signals, rather than a detectable mechanical or major motor abnormality.

Esophageal Visceral Hypersensitivity

Visceral hypersensitivity is likely the central mechanism in functional dysphagia. Patients with this condition may have a lowered threshold for perceiving esophageal distension, bolus contact, or esophageal contractions. Normal physiological events during swallowing (bolus transit, peristaltic contraction, transient distension of the esophageal wall) that are imperceptible to healthy individuals may be perceived as abnormal or obstructive by patients with heightened esophageal sensitivity.

This hypersensitivity may be peripheral (sensitization of esophageal mucosal or submucosal afferent nerves) or central (amplification of visceral signals in the brainstem, thalamus, or cortex). Peripheral sensitization may be triggered by prior mucosal injury (e.g., from acid reflux, pill esophagitis, or infection) even after the injury itself has healed, a phenomenon analogous to post-inflammatory visceral hypersensitivity described in IBS.

Minor Esophageal Motor Abnormalities

While major motor disorders are excluded by Rome IV criteria, many patients with functional dysphagia have minor or borderline manometric abnormalities that may contribute to their symptoms. Ineffective esophageal motility (IEM), characterized by weak or failed peristaltic contractions, is found in a significant proportion of patients with dysphagia who do not meet criteria for any major disorder. Fragmented peristalsis (large peristaltic breaks greater than 5 cm) is another minor finding.

These minor motor abnormalities may impair bolus clearance just enough to be perceptible to a sensitized patient, even though they would not cause symptoms in a patient with normal esophageal sensitivity. The combination of minor dysmotility and visceral hypersensitivity may be the pathophysiological signature of functional dysphagia in many cases.

Bolus Transit Abnormalities

Impedance planimetry (EndoFLIP) and combined high-resolution impedance manometry (HRIM) studies have revealed that some patients with functional dysphagia have subtle abnormalities in bolus transit that are not captured by conventional HRM alone. These may include delayed bolus transit through segments of the esophagus, increased intrabolus pressure, or abnormal esophageal body distensibility. The clinical significance of these findings is still under investigation, but they support the concept that functional dysphagia is not simply "nothing wrong" but rather involves real, if subtle, physiological disturbances.

Brain-Esophagus Axis Dysfunction

As with other DGBI, the brain-gut (or brain-esophagus) axis plays an important role in functional dysphagia. Central processing of swallowing-related sensory information is mediated by a complex neural network involving the brainstem swallowing center, the nucleus tractus solitarius, the thalamus, the insular cortex, the anterior cingulate cortex, and the prefrontal cortex. Functional neuroimaging studies have demonstrated altered cortical activation patterns in patients with functional esophageal disorders, suggesting that central sensitization and altered top-down modulation of esophageal perception contribute to symptoms.

Psychological factors, including anxiety, health-related hypervigilance, catastrophizing, and somatization, can amplify esophageal sensory signals through descending facilitation pathways and reduced descending inhibition. Many patients with functional dysphagia report that their symptoms worsen during periods of stress, consistent with a central modulatory contribution.

Esophageal Mucosal Integrity

Emerging research has explored whether subtle alterations in esophageal mucosal integrity (intercellular space dilation, altered tight junction protein expression, increased mucosal permeability) may sensitize esophageal afferents in some patients with functional esophageal disorders, even in the absence of visible mucosal injury on endoscopy. These "microscopic" mucosal changes could lower the threshold for esophageal sensation and contribute to functional dysphagia. However, this hypothesis remains investigational.

Clinical Evaluation and Required Workup

Functional dysphagia demands a more extensive workup than many other DGBI because dysphagia is inherently an alarm symptom that may signal serious organic disease. The diagnostic evaluation should be systematic, proceeding from less invasive to more invasive investigations as clinically indicated.

Step 1: Detailed History

The clinical history should characterize:

• Type of dysphagia: Oropharyngeal versus esophageal (ask whether food gets stuck when initiating a swallow or during passage through the chest).
• Solids versus liquids: Dysphagia to solids alone suggests mechanical obstruction; dysphagia to both solids and liquids from the outset suggests a motility disorder. Functional dysphagia may involve either pattern.
• Onset and progression: Progressive dysphagia (worsening over weeks to months) raises concern for malignancy or stricture. Intermittent dysphagia with a stable course is more consistent with a ring, web, or functional cause.
• Frequency and duration: Rome IV requires weekly frequency for at least 3 months with onset at least 6 months prior.
• Associated symptoms: Heartburn, regurgitation, weight loss, odynophagia (pain on swallowing), food bolus impaction episodes, atopic history (suggesting EoE), and neurological symptoms.
• Medication history: Pill esophagitis (bisphosphonates, doxycycline, potassium chloride, iron, NSAIDs, quinidine), opioids (which can cause esophageal dysmotility and EGJ outflow obstruction), and anticholinergics.
• Psychosocial assessment: Anxiety, depression, somatization, prior trauma, and the patient's illness model and expectations.

Step 2: Upper Endoscopy (EGD) with Biopsies

EGD is the first-line investigation for esophageal dysphagia. It allows direct visualization of the esophageal mucosa to identify strictures, rings, webs, tumors, esophagitis, and other mucosal abnormalities. Critically, esophageal biopsies must be obtained from multiple levels (at least proximal and distal esophagus, two to four biopsies per level) to evaluate for eosinophilic esophagitis, which may have a grossly normal or subtly abnormal endoscopic appearance.

If endoscopy reveals a structural or mucosal cause for dysphagia, that diagnosis takes precedence and functional dysphagia is not diagnosed.

Step 3: Barium Esophagography

A barium swallow study, ideally including a solid bolus challenge (barium tablet or marshmallow), complements endoscopy by providing dynamic imaging of esophageal anatomy and bolus transit. It is particularly valuable for identifying subtle Schatzki rings (which may not be evident on endoscopy if the esophagus is not maximally distended), esophageal webs, extrinsic compression, and diverticula. Timed barium esophagogram (TBE) can also provide a functional assessment of esophageal emptying, which is useful in evaluating achalasia and EGJ outflow obstruction.

Step 4: Reflux Evaluation

If GERD is suspected as a contributor to dysphagia, evaluation may include an empiric PPI trial (8 weeks of twice-daily dosing) and/or ambulatory reflux monitoring (24-hour pH or pH-impedance study). Resolution of dysphagia with PPI therapy supports a GERD-related mechanism and argues against functional dysphagia.

Step 5: High-Resolution Manometry (HRM)

HRM is the gold-standard test for evaluating esophageal motor function and is essential for excluding the major esophageal motor disorders required by Rome IV criterion 4. The study involves transnasal placement of a solid-state catheter with closely spaced pressure sensors spanning the pharynx through the stomach. The patient performs a series of liquid swallows (typically ten 5-mL water swallows), and the resulting pressure data are analyzed according to the Chicago Classification of esophageal motility disorders.

HRM should be performed in all patients with esophageal dysphagia when endoscopy and barium studies do not reveal a structural cause. If HRM identifies achalasia, DES, jackhammer esophagus, or absent peristalsis, the diagnosis is that specific major motor disorder, not functional dysphagia.

Adjunctive Tests

In selected cases, additional testing may be helpful:

• EndoFLIP (endoluminal functional lumen imaging probe): Measures esophageal body and EGJ distensibility. May identify subtle EGJ obstruction missed on HRM and is increasingly used in achalasia evaluation and post-treatment assessment.
• Combined high-resolution impedance manometry (HRIM): Adds bolus transit assessment to standard HRM, potentially identifying transit abnormalities in patients with normal pressure topography.
• Provocative testing during manometry: Solid swallows, multiple rapid swallows, or a test meal (free drinking) challenge may unmask motility abnormalities not evident on standard liquid swallow protocol.
• CT or MRI of the chest: If extrinsic compression is suspected.

The Chicago Classification and Its Relationship to Functional Dysphagia

The Chicago Classification of esophageal motility disorders is the international standard for interpreting HRM results and is integral to applying Rome IV criterion 4. The classification (now in version 4.0, published in 2021) organizes motility findings into a hierarchical diagnostic framework:

1. Disorders of EGJ outflow: Achalasia (Types I, II, III) and EGJ outflow obstruction.
2. Major disorders of peristalsis: Absent contractility, distal esophageal spasm, hypercontractile esophagus (jackhammer).
3. Minor disorders of peristalsis: Ineffective esophageal motility (IEM), fragmented peristalsis.
4. Normal motility.

For Rome IV functional dysphagia, only categories 1 and 2 (disorders of EGJ outflow and major disorders of peristalsis) must be excluded. Categories 3 (minor disorders) and 4 (normal) are compatible with a diagnosis of functional dysphagia. This is an important nuance: a patient with dysphagia and ineffective esophageal motility on HRM, but no major motor disorder, may still qualify for functional dysphagia under Rome IV, provided all other criteria are met.

The Chicago Classification v4.0 also introduced the concept of "conclusive" versus "inconclusive" EGJ outflow obstruction, recommending confirmatory testing (EndoFLIP, timed barium esophagogram, or provocative manometry) for inconclusive cases. This refinement is relevant to functional dysphagia diagnosis because some patients initially classified as having EGJ outflow obstruction on standard HRM may be reclassified as having normal EGJ function after confirmatory testing, potentially becoming eligible for a functional dysphagia diagnosis.

Differential Diagnosis

The differential diagnosis for esophageal dysphagia is broad and encompasses structural, inflammatory, motor, and functional etiologies. A systematic approach is essential:

• Structural causes: Esophageal stricture (peptic, caustic, radiation, anastomotic), Schatzki ring, esophageal web, esophageal malignancy (squamous cell carcinoma, adenocarcinoma), extrinsic compression (mediastinal mass, vascular anomaly, enlarged left atrium), esophageal diverticulum.
• Inflammatory causes: Eosinophilic esophagitis, erosive esophagitis (GERD), pill esophagitis, infectious esophagitis (Candida, herpes simplex virus, cytomegalovirus, particularly in immunocompromised patients), radiation esophagitis.
• Major motor disorders: Achalasia (Types I, II, III), EGJ outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, absent peristalsis.
• Systemic diseases: Systemic sclerosis (scleroderma esophagus), other connective tissue diseases, amyloidosis, sarcoidosis.
• Oropharyngeal dysphagia: Neurological (stroke, Parkinson disease, ALS, myasthenia gravis), structural (Zenker diverticulum, cricopharyngeal bar, head/neck tumor), muscular (polymyositis, dermatomyositis).
• Other functional esophageal disorders: Globus (sensation of a lump in the throat without dysphagia), functional chest pain, reflux hypersensitivity.

Management Strategies

Management of functional dysphagia is challenging because no single therapy has been validated in large randomized controlled trials. Treatment is individualized and often multimodal, drawing on the same principles applied to other functional esophageal disorders and DGBI more broadly.

Patient Education and Reassurance

The cornerstone of management is a clear, empathetic explanation of the diagnosis. Patients with functional dysphagia often harbor significant anxiety about the possibility of cancer, stricture, or progressive neurological disease. Explaining that thorough evaluation has excluded these conditions, and that functional dysphagia reflects altered esophageal sensitivity rather than structural damage, can itself reduce symptom burden. Framing the condition within the gut-brain interaction model helps patients understand why stress and anxiety may worsen their symptoms and why psychological interventions may be relevant.

Dietary and Behavioral Modifications

• Eating modifications: Taking smaller bites, chewing food thoroughly, eating slowly, and drinking liquids with solid food can facilitate esophageal transit and reduce the perception of sticking.
• Avoidance of trigger foods: Some patients identify specific food textures (dry bread, rice, tough meats) that consistently provoke dysphagia. Modifying the diet to avoid or prepare these foods differently can be helpful.
• Upright posture during and after meals: Maintaining an upright position during eating and for at least 30 minutes afterward may promote gravity-assisted esophageal clearance.
• Stress management: Since anxiety and stress can amplify esophageal hypersensitivity, relaxation techniques, deep breathing exercises, and mindfulness practices may be beneficial adjuncts.

Acid-Suppressive Therapy

A trial of PPI therapy is often undertaken during the diagnostic process to exclude GERD-related dysphagia. In some patients with functional dysphagia, continued PPI use may provide modest benefit, potentially by reducing subclinical acid-mediated mucosal sensitization. However, PPIs are not expected to be the primary therapy for functional dysphagia, and prolonged use should be guided by clinical response rather than continued empirically.

Central Neuromodulators

Neuromodulators that target visceral hypersensitivity and central pain/sensation processing are increasingly used in functional esophageal disorders:

• Tricyclic antidepressants (TCAs): Low-dose imipramine, amitriptyline, or nortriptyline (10 to 50 mg at bedtime) may reduce esophageal visceral hypersensitivity through peripheral and central mechanisms. TCAs have the best evidence base among neuromodulators for functional esophageal disorders, though data specific to functional dysphagia are limited.
• SSRIs and SNRIs: Sertraline, citalopram, escitalopram, venlafaxine, and duloxetine have been used in functional esophageal disorders with variable results. They may be particularly helpful when comorbid anxiety or depression is present.
• Trazodone: Has been studied in functional esophageal disorders and may improve esophageal symptoms through serotonergic modulation and smooth muscle relaxation.
• Buspirone: A 5-HT1A agonist that has demonstrated esophageal smooth muscle relaxation and improved esophageal accommodation in research settings. It may be considered in patients with concurrent anxiety.

Smooth Muscle Relaxants and Motility Modulators

In patients whose functional dysphagia may be partly related to minor motor abnormalities (ineffective motility, mild spastic features that do not meet criteria for DES or jackhammer), smooth muscle relaxants such as calcium channel blockers (diltiazem, nifedipine), nitrates, or peppermint oil may provide symptom relief. These agents have been studied primarily in spastic esophageal disorders and their efficacy in functional dysphagia per se is extrapolated rather than proven.

Empiric Esophageal Dilation

Bougie dilation of the esophagus (passage of a dilator through the esophageal lumen, typically to 50-54 French) has been used empirically in some patients with functional dysphagia, even in the absence of a visible stricture or ring. The rationale is that dilation may disrupt subtle areas of reduced distensibility not detected by standard testing, and the mechanical stretching itself may "reset" esophageal sensory pathways. Some case series and small studies have reported symptom improvement with empiric dilation, but the evidence base is limited and the benefit may not be sustained. This approach should be reserved for carefully selected patients after thorough discussion of risks and benefits.

Psychological Therapies

• Cognitive behavioral therapy (CBT): Can address catastrophizing, hypervigilance, and maladaptive illness behaviors that amplify dysphagia symptoms. CBT has demonstrated efficacy in other functional esophageal disorders and may benefit functional dysphagia patients, particularly those with prominent psychological comorbidity.
• Esophageal-directed hypnotherapy: Analogous to gut-directed hypnotherapy for IBS, esophageal-directed hypnotherapy targets the modulation of esophageal sensory processing. Early evidence is promising but limited.
• Biofeedback: Esophageal biofeedback, sometimes combined with manometric feedback during swallowing exercises, has been explored in small studies as a means to improve swallowing coordination and reduce symptom perception.

Using the Rome IV Functional Dysphagia Calculator

The Rome IV Functional Dysphagia diagnostic criteria calculator is a clinical decision-support tool designed to systematically evaluate whether a patient meets the Rome IV criteria for functional dysphagia (A5). The calculator assesses each of the four diagnostic criteria and all three temporal/frequency requirements individually, then aggregates the results to determine whether all criteria are satisfied.

The calculator evaluates seven elements:

1. Whether the patient reports a sense of solid and/or liquid foods sticking, lodging, or passing abnormally through the esophagus.
2. Whether appropriate evaluation has excluded an esophageal mucosal or structural abnormality as the cause.
3. Whether appropriate evaluation has excluded gastroesophageal reflux and eosinophilic esophagitis as the cause.
4. Whether high-resolution manometry has excluded achalasia/EGJ outflow obstruction, diffuse esophageal spasm, jackhammer esophagus, and absent peristalsis.
5. Whether symptoms have been present for the last 3 months.
6. Whether symptom onset occurred at least 6 months before the current evaluation.
7. Whether symptoms occur at least once per week.

All seven elements must be affirmed for a positive result. If any element is not satisfied, the calculator identifies which specific criteria are unmet and suggests consideration of the relevant differential diagnoses. This tool is intended for educational and clinical decision-support purposes. It does not replace the clinical judgment of a qualified healthcare provider, and it assumes that appropriate investigations (endoscopy with biopsies, reflux evaluation, and high-resolution manometry) have been performed or are being planned.

Overlap with Other Functional Esophageal Disorders

Functional dysphagia exists within a spectrum of functional esophageal disorders defined by Rome IV. Patients may have features of more than one condition simultaneously, and symptoms may evolve over time.

Globus (A4) is the persistent or intermittent sensation of a lump, foreign body, or tightness in the throat that is not associated with swallowing and does not interfere with eating or drinking. Globus and functional dysphagia are distinct conditions, but some patients describe symptoms that blur the boundary, such as a throat tightness that they perceive as affecting swallowing. Careful symptom characterization is necessary to distinguish the two.

Functional heartburn (A2) and reflux hypersensitivity (A3) may coexist with functional dysphagia, as all three conditions involve altered esophageal sensory processing. A patient with functional dysphagia who also reports burning in the retrosternal area without pathological acid exposure may have concurrent functional heartburn.

Functional chest pain (A1) may overlap with functional dysphagia in patients whose esophageal hypersensitivity manifests both as perceived bolus obstruction and as non-cardiac chest pain. These patients may benefit from neuromodulator therapy that addresses the shared pathophysiology of visceral hypersensitivity.

Functional dysphagia also overlaps with lower GI DGBI, particularly IBS and functional dyspepsia. The co-occurrence of upper and lower GI functional disorders reflects the systemic nature of gut-brain interaction abnormalities, including generalized visceral hypersensitivity, central sensitization, and psychosocial modulation of symptom perception.

Prognosis and Natural History

The natural history of functional dysphagia is not well characterized by long-term prospective studies, but available data suggest a chronic, fluctuating course. Some patients experience periods of improvement or remission, while others have persistent symptoms that wax and wane with stress, illness, and dietary changes. Spontaneous complete resolution is possible but may not be the norm.

Functional dysphagia does not progress to cancer, stricture, achalasia, or other serious organic disease. This reassurance is therapeutically important and should be communicated clearly to patients. However, patients with a functional dysphagia diagnosis who develop new alarm features (progressive worsening, weight loss, food bolus impaction requiring emergency disimpaction, new-onset vomiting) should be re-evaluated promptly because organic diseases can emerge over time independently of the functional diagnosis.

Quality of life may be significantly impacted by functional dysphagia. Patients may restrict their diet, avoid eating in social settings, eat slowly or less, and experience anxiety related to meals. Addressing these functional limitations through dietary counseling, psychological support, and pharmacological management can meaningfully improve the patient's daily life even when complete symptom resolution is not achieved.